Consistent with prior reports of MCC dependency on survivin32, we found that pharmacological inhibition of survivin or its siRNA knockdown more potently reduced VP-MCC viability relative to VN-MCC (Supplementary Fig. S8A, C). The gene discussed is MCC; the disease is Merkel cell skin cancer.